Beijing Winsunny Pharmaceutical CO.LTD (601089) — Cash Flow Reinvestment Rate
Beijing Winsunny Pharmaceutical CO.LTD (601089) has a Cash Flow Reinvestment Rate of 0.58x as of December 2024, reinvesting CN¥403.39 Million (capex CN¥391.52 Million plus investments CN¥11.87 Million) from operating cash flow of CN¥690.75 Million. See Beijing Winsunny Pharmaceutical CO.LTD free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Beijing Winsunny Pharmaceutical CO.LTD Cash Flow Reinvestment Rate (2020–2024)
Historical reinvestment intensity for Beijing Winsunny Pharmaceutical CO.LTD across 5 annual periods. For the full cash flow conversion analysis, see 601089 cash flow metrics.
Annual Cash Flow Reinvestment Rate for Beijing Winsunny Pharmaceutical CO.LTD (2020–2024)
Year-by-year capital reinvestment analysis for Beijing Winsunny Pharmaceutical CO.LTD. See Beijing Winsunny Pharmaceutical CO.LTD (601089) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.58x | CN¥403.39 Million | CN¥690.75 Million | CN¥391.52 Million | ▼ -11.9% |
| 2023 | 0.66x | CN¥368.49 Million | CN¥555.90 Million | CN¥366.08 Million | ▲ +162.2% |
| 2022 | 0.25x | CN¥166.81 Million | CN¥659.76 Million | CN¥135.40 Million | ▼ -69.2% |
| 2021 | 0.82x | CN¥433.12 Million | CN¥528.02 Million | CN¥192.97 Million | ▼ -21.1% |
| 2020 | 1.04x | CN¥401.81 Million | CN¥386.65 Million | CN¥168.96 Million | — |